196 related articles for article (PubMed ID: 37280265)
1. Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations.
Otum CC; Rivière E; Barnard M; Loubser J; Williams MJ; Streicher EM; Van Rie A; Warren RM; Klopper M
Sci Rep; 2023 Jun; 13(1):9212. PubMed ID: 37280265
[TBL] [Abstract][Full Text] [Related]
2. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
[TBL] [Abstract][Full Text] [Related]
3. Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
Peretokina IV; Krylova LY; Antonova OV; Kholina MS; Kulagina EV; Nosova EY; Safonova SG; Borisov SE; Zimenkov DV
J Infect; 2020 May; 80(5):527-535. PubMed ID: 31981638
[TBL] [Abstract][Full Text] [Related]
4. Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis.
Xu J; Li D; Shi J; Wang B; Ge F; Guo Z; Mu X; Nuermberger E; Lu Y
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0153222. PubMed ID: 37255473
[TBL] [Abstract][Full Text] [Related]
5.
Ismail N; Ismail NA; Omar SV; Peters RPH
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138569
[TBL] [Abstract][Full Text] [Related]
6. atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure.
Le Ray LF; Aubry A; Sougakoff W; Revest M; Robert J; Bonnet I; Veziris N; Morel F
Emerg Infect Dis; 2022 May; 28(5):1062-1064. PubMed ID: 35447056
[TBL] [Abstract][Full Text] [Related]
7. Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
Zimenkov DV; Nosova EY; Kulagina EV; Antonova OV; Arslanbaeva LR; Isakova AI; Krylova LY; Peretokina IV; Makarova MV; Safonova SG; Borisov SE; Gryadunov DA
J Antimicrob Chemother; 2017 Jul; 72(7):1901-1906. PubMed ID: 28387862
[TBL] [Abstract][Full Text] [Related]
8. Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in
Guo Q; Bi J; Lin Q; Ye T; Wang Z; Wang Z; Liu L; Zhang G
Front Cell Infect Microbiol; 2022; 12():807095. PubMed ID: 35694543
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants and their association with phenotypic resistance to bedaquiline in
Ismail N; Rivière E; Limberis J; Huo S; Metcalfe JZ; Warren RM; Van Rie A
Lancet Microbe; 2021 Nov; 2(11):e604-e616. PubMed ID: 34796339
[TBL] [Abstract][Full Text] [Related]
10. Mutation in
Singh BK; Soneja M; Sharma R; Chaubey J; Kodan P; Jorwal P; Nischal N; Chandra S; Ramachandran R; Wig N
Int J Mycobacteriol; 2020; 9(2):212-215. PubMed ID: 32474547
[TBL] [Abstract][Full Text] [Related]
11. Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia.
Martinez E; Hennessy D; Jelfs P; Crighton T; Chen SC; Sintchenko V
Tuberculosis (Edinb); 2018 Jul; 111():31-34. PubMed ID: 30029911
[TBL] [Abstract][Full Text] [Related]
12. Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan.
Saeed DK; Shakoor S; Razzak SA; Hasan Z; Sabzwari SF; Azizullah Z; Kanji A; Nasir A; Shafiq S; Ghanchi NK; Hasan R
BMC Microbiol; 2022 Feb; 22(1):62. PubMed ID: 35209842
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics and in vitro susceptibility to bedaquiline of Mycobacterium tuberculosis isolates circulating in Shaanxi, China.
Yang J; Pang Y; Zhang T; Xian X; Li Y; Wang R; Wang P; Zhang M; Wang J
Int J Infect Dis; 2020 Oct; 99():163-170. PubMed ID: 32738481
[TBL] [Abstract][Full Text] [Related]
14. Identification of genetic determinants of bedaquiline resistance in
Umpeleva T; Chetverikova E; Belyaev D; Eremeeva N; Boteva T; Golubeva L; Vakhrusheva D; Vasilieva I
Microbiol Spectr; 2024 Mar; 12(3):e0374923. PubMed ID: 38345388
[TBL] [Abstract][Full Text] [Related]
15. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.
Nimmo C; Millard J; van Dorp L; Brien K; Moodley S; Wolf A; Grant AD; Padayatchi N; Pym AS; Balloux F; O'Donnell M
Lancet Microbe; 2020 Aug; 1(4):e165-e174. PubMed ID: 32803174
[TBL] [Abstract][Full Text] [Related]
16. Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
Brown TS; Tang L; Omar SV; Joseph L; Meintjes G; Maartens G; Wasserman S; Shah NS; Farhat MR; Gandhi NR; Ismail N; Brust JCM; Mathema B
Clin Infect Dis; 2024 Feb; 78(2):269-276. PubMed ID: 37874928
[TBL] [Abstract][Full Text] [Related]
17. Sub-MIC levels of bedaquiline and clofazimine can select
Villellas C; Stevenaert F; Remmerie B; Andries K
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0127523. PubMed ID: 38470194
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.
Battaglia S; Spitaleri A; Cabibbe AM; Meehan CJ; Utpatel C; Ismail N; Tahseen S; Skrahina A; Alikhanova N; Mostofa Kamal SM; Barbova A; Niemann S; Groenheit R; Dean AS; Zignol M; Rigouts L; Cirillo DM
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32907992
[TBL] [Abstract][Full Text] [Related]
19. A case of primary multidrug-resistant pulmonary tuberculosis with high minimum inhibitory concentration value for bedaquiline.
Kobayashi M; Motoki Y; Yamagishi T; Hirano H; Nonaka M; Aono A; Mitarai S; Saito T
J Infect Chemother; 2022 Aug; 28(8):1193-1197. PubMed ID: 35550867
[TBL] [Abstract][Full Text] [Related]
20. Clofazimine Exposure
Ismail N; Peters RPH; Ismail NA; Omar SV
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]